Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib

Buffet C.a,b· Leboulleux S.c· Kraeber-Bodéré F.d,e· Bodet-Milin C.d,e· Cabanes L.g,n· Dohan A.h,i· Leprince P.j· Schlumberger M.b,k· Huillard O.f,l· Groussin L.m,n,o

Author affiliations

aDepartment of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France
bUMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
cDepartment of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France
dNuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
eCHU Nantes/ICO, Saint-Herblain, France
fUniversité de Paris, Sorbonne Paris Cité, Paris, France
gDepartment of Cardiology, APHP, Cochin Hospital, Paris, France
hRadiology Department, Université de Paris, Paris, France
iDepartment of Radiology, AP-HP, Hôpital Cochin, Paris, France
jDepartment of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
kDepartment of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France
lDepartment of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France
mINSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France
nUniversité de Paris, Paris, France
oDepartment of Endocrinology, AP-HP, Hôpital Cochin, Paris, France

留言 (0)

沒有登入
gif